Rosett most recently held the role of Executive Vice President, Operations, in addition to serving as Immunome's Interim Chief Financial Officer since January 2024.
Immunome Promotes Max Rosett To CFO, Effective May 9
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.